A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation-Reference-Cited by-同舟云学术

A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Published:2015-07-05 Issue:10 Volume:94 Page:1733-1740
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Sakellari Ioanna,Angelopoulou Maria,Tsopra Olga,Dervenoulas Ioannis,Tsirigotis Panagiotis,Spyridonidis Alexandros,Liga Maria,Tsionos Konstantinos,Anargyrou Konstantinos,Pouli Anastasia,Anagnostopoulos Achilles

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2437-5.pdf

Reference45 articles.

1. Farooq U, Laport GG (2014) Recent progress: hematopoietic cell transplantation for diffuse large B cell lymphoma. Leuk Lymphoma: 1–22

2. Stiff P (2001) Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27(Suppl 2):S3–S11

3. Pico JL, Avila-Garavito A (1998) Naccache et al. P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 3:446–451

4. Bey A, Ahmed SS, Hussain B, Devi S et al (2010) Prevention and management of antineoplastic therapy induced oral mucositis. Natl J Maxillofac Surg 1:127–134

5. Sonis S, Clark J (1991) Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 5:11–18

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between salivary inflammatory mediators and oral mucositis in patients with cancer undergoing chemotherapy;Supportive Care in Cancer;2024-09

2. Evaluating the psychometric properties of the simplified Chinese version of PROMIS-29 version 2.1 in patients with hematologic malignancies;Scientific Reports;2024-05-15

3. Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT;Hematology, Transfusion and Cell Therapy;2023-07

4. Viable Bifidobacterium tablets for the prevention of chemotherapy-/radiation-induced mucositis in patients undergoing haematopoietic stem cell transplantation;Supportive Care in Cancer;2023-04-19

5. Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study;PLOS ONE;2022-04-27